Kenneth Brayman, MD
Transplant Surgery · Charlottesville, VANPI 1306915921
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (51.8%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Veloxis Pharmaceuticals, Inc. accounts for 78.9% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2020 at $7,030 and has fallen 98.4% since, to $112 in 2024.
Across 30 payments — averaging $569.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veloxis Pharmaceuticals, Inc.$13K
- La Jolla Pharmaceutical Company$3K
- Vertex$508
- Takeda Pharmaceuticals U.S.A., Inc.$119
- Merck$112
- Otsuka America Pharmaceutical, Inc.$17
- plus $11 from 1 others
What the payments were for
- Consulting fees$8,84852%
- Speaking & faculty fees$1,0506%
- Travel & lodging$6,35337%
- Food & beverage$8225%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veloxis Pharmaceuticals, Inc. | 24 | $13,466 |
| La Jolla Pharmaceutical Company | 1 | $2,840 |
| Vertex | 1 | $508 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $119 |
| Merck | 1 | $112 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Envarsus$18,114
- GIAPREZA$2,840
- LIVTENCITY$119
- PREVYMIS$112
How this compares
Too few transplant surgery providers in Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Charlottesville
- Timothy PruettCharlottesville$24K
- Josef OberholzerCharlottesville$21K
- Yazan Abu Orabi Al-AdwanCharlottesville$9K
- Danielle LadieCharlottesville$7K
- Nicolas GoldaracenaCharlottesville$5K
- Shawn PelletierCharlottesville$1K
- Juan F Guerra CastroCharlottesville$245
- Avinash AgarwalCharlottesville$147
- Stephanie SilpeCharlottesville$131
- Seung LeeRichmond$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.